glp-1 substance use disorder Glucagon-like peptide-1 medicines in neurological and psychiatric disorders: Cell Reports Medicine Glucagon-like peptide-1 receptor agonists and
Description
Author contributions QL: Conceptualization, Data curation, Formal analysis, Writing original draft, Writing review & editing
Liraglutide inhibited AGEs induced coronary smooth muscle cell phenotypic transition through inhibiting the NF-B signal pathway
Effect of Liraglutide on Osteoporosis in a Rat Model of Type 2 Diabetes Mellitus: A Histological, Immunohistochemical, and Biochemical Study
The barrier to entry is multi-layered
This means food stays in the stomach for longer before digestion
